Compound information
- Natural Products
- ZC2139359
- Molecular Formula
- C19H22ClN3O
- Molecular Weight
- 343.145140004 g/mol
- Structure
-
- IUPAC Name
- 4-[(3-chlorophenyl)methyl]-N-(p-tolyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C19H22ClN3O/c1-15-5-7-18(8-6-15)21-19(24)23-11-9-22(10-12-23)14-16-3-2-4-17(20)13-16/h2-8,13H,9-12,14H2,1H3,(H,21,24)
- InChI Key
- HWDMGHXQQRXJRG-UHFFFAOYSA-N
- SMILES
- Cc1ccc(NC(=O)N2CCN(Cc3cccc(Cl)c3)CC2)cc1
- Source
- ZINC000020367781
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 5 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 35.58 Å2 | LogP | 3.94 |
LogS | -4.194 | LogD | 4.138 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.996 | Pgp substrate | 0.966 |
HIA | 0.969 | F20 % | 0.989 |
F30 % | 0.975 | Caco-2 | -4.705 |
MDCK | -4.711 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.462 | PPB | 97.589 |
VD | 1.217 | Fu | 1.185 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.013 | CYP1A2 substrate | 0.798 |
CYP2A6 substrate | 0.841 | CYP2B6 substrate | 0.647 |
CYP2C19 inhibitor | 0.969 | CYP2C19 substrate | 0.955 |
CYP2C8 substrate | 0.933 | CYP2C9 inhibitor | 0.607 |
CYP2C9 substrate | 0.762 | CYP2D6 inhibitor | 0.918 |
CYP2D6 substrate | 0.995 | CYP2E1 substrate | 0.924 |
CYP3A4 inhibitor | 0.26 | CYP3A4 substrate | 0.988 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.297 | CL | 9.761 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.993 | Hepatotoxicity | 0.87 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.806 |
FDAMDD | 0.373 | Skin Sensitization | 0.907 |
Carcinogenicity | 0.087 | Eye Corrosion | 0.001 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.852 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.557 | IGC50 | 3.762 |
LC50FM | 3.746 | LC50DM | -1.974 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.393 | NR-AR-LBD | 0.187 |
NR-AhR | 0.664 | NR-Aromatase | 0.029 |
NR-ER | 0.349 | NR-ER-LBD | 0.295 |
NR-PPAR-gamma | 0.192 | SR-ARE | 0.882 |
SR-ATAD5 | 0.353 | SR-HSE | 0.12 |
SR-MMP | 0.075 | SR-p53 | 0.094 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.